Prime Medicine, Inc. (PRME)
NASDAQ
3.12
-0.02 (-0.64%)
Closed
Sep 18, 2026
Day's Range
3.043.17
52 wk Range
2.676.94
Financial Statements - PRME - Prime Medicine, Inc.
Revenue
4.63M▲ 55.3%
Net Income
-201.14M▼ 2.7%Net Margin -4342.4%
EBITDA
-201.46M▼ 2.9%
Free Cash Flow
-167.09M▼ 28.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 4.63M | 2.98M | 0 | 0 | 0 | 5.21M |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -208.35M | -202.46M | -191.29M | -116.54M | -84.47M | -932K |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 3.05M | 3.06M | -7.12M | -6.22M | -81.37M | -611K |
| Pre Tax Income | -201.14M | -195.88M | -198.41M | -122.76M | -165.85M | -1.54M |
| Income Tax | - | 0 | -279K | -948K | -486K | 1.86M |
| Net Income | -201.14M | -195.88M | -198.13M | -121.82M | -165.36M | -3.41M |
| EPS Basic | -1.35 | -1.65 | -2.18 | -4.19 | -2.564492 | -0.070408 |
| EPS Diluted | -1.35 | -1.65 | -2.18 | -4.19 | -2.564492 | -0.070408 |
| Basic Shares Outstanding | 148.75M | 118.60M | 90.96M | 33.89M | 71.79M | 71.79M |
| Diluted Shares Outstanding | 148.75M | 118.60M | 90.96M | 33.89M | 71.79M | 71.79M |
| Ebit | -208.35M | -202.46M | -191.29M | -116.54M | -84.47M | -932K |
| Ebitda | -201.46M | -195.85M | -170.75M | -106.19M | -83.51M | -11.75M |
| Net Income Continuous Operations | -201.14M | -195.88M | -198.13M | -121.82M | -165.36M | -3.41M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | 0 | 1.46M | 1.64M |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
